Equasym xr 20 mg

Equasym XL 20 mg Modified-Release Capsules

Equasym XL 20 mg is a prescription-only central nervous system (CNS) stimulant designed as part of a comprehensive treatment program for Attention Deficit Hyperactivity Disorder (ADHD). Formulated with methylphenidate hydrochloride, this modified-release capsule is specifically engineered to align with the typical school or workday schedule, providing a balanced, dual-action release of medication.

How Equasym XL 20 mg Works

Equasym XL utilizes a specialized delivery system that features a 30% immediate-release component and a 70% extended-release component.

• The Immediate Phase: Delivers an initial 6 mg dose of methylphenidate to help kickstart focus and concentration in the morning.

• The Extended Phase: Gradually releases the remaining 14 mg throughout the afternoon, eliminating the need for a midday lunchtime dose.

By targeting and balancing specific neurotransmitters (dopamine and norepinephrine) in the brain, it helps improve attention spans, enhance cognitive focus, and minimize impulsive or hyperactive behaviors.

Product Specifications & Key Information

Important Dosage & Safety Guidelines

• Administration: The capsule should be swallowed with the fluids. Alternatively, for individuals who have difficulty swallowing, the capsule may be opened and its contents sprinkled onto a tablespoon of applesauce to be consumed immediately.

• Storage: Store below 25°C (77°F) in a dry place, out of the sight and reach of children.

• Contraindications: Do not use if there is a history of severe cardiovascular disorders, severe hypertension, glaucoma, hyperthyroidism, or severe anxiety/depression. You should always consult a specialist before initiating or adjusting treatment.